E. Kevin Hrusovsky - 03 Aug 2021 Form 4 Insider Report for Quanterix Corp (QTRX)

Reporting relationship: Chairman, President & CEO, Director
Issuer ticker: QTRX
Reported as of: 03 Aug 2021
Net transaction value: -$196,219
SEC form: 4
Accepted by SEC: 03 Aug 2021, 21:34:30 UTC
Prior SEC filing: 30 Jul 2021
Next SEC filing: 18 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Brian Keane, as Attorney-in-Fact

Key filing fact

E. Kevin Hrusovsky filed Form 4 for Quanterix Corp (QTRX) on 03 Aug 2021.

Key facts

This page summarizes E. Kevin Hrusovsky's Form 4 filing for Quanterix Corp (QTRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Aug 2021, 21:34.

Change

Previous filing in this sequence was filed on 30 Jul 2021.
Current net transaction value: -$196,219.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTRX transaction

Common Stock

Sale

Transaction value: $196,219
Shares: -3,648
Change %: -0.39%
Price: $53.79
Shares after: 933,619
Date: 03 Aug 2021
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $53.43 to $53.99. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

Includes 89,309 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.